{"id":34743,"date":"2025-08-31T14:15:09","date_gmt":"2025-08-31T14:15:09","guid":{"rendered":"https:\/\/www.europesays.com\/ie\/34743\/"},"modified":"2025-08-31T14:15:09","modified_gmt":"2025-08-31T14:15:09","slug":"eli-lilly-partners-with-china-tech-giant-for-obesity-drug-sales","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/ie\/34743\/","title":{"rendered":"Eli Lilly Partners With China Tech Giant for Obesity Drug Sales"},"content":{"rendered":"<p class=\"media-ui-Paragraph_text-SqIsdNjh0t0-\" data-component=\"paragraph\"><a href=\"https:\/\/www.bloomberg.com\/quote\/LLY:US\" target=\"_blank\" rel=\"noopener nofollow\" class=\"media-ui-Link_link-tVkXhPLPofs-\" data-component=\"link\">Eli Lilly &amp; Co<\/a> is partnering with Chinese online healthcare platform <a href=\"https:\/\/www.bloomberg.com\/quote\/6618:HK\" target=\"_blank\" rel=\"noopener nofollow\" class=\"media-ui-Link_link-tVkXhPLPofs-\" data-component=\"link\">JD Health International Inc.<\/a> to sell its blockbuster drugs for obesity and diabetes online, following in competitors\u2019 footsteps to drive sales through direct-to-consumer channels. <\/p>\n<p class=\"media-ui-Paragraph_text-SqIsdNjh0t0-\" data-component=\"paragraph\">The tie-up will ease access to Lilly\u2019s drugs treating obesity, diabetes and alopecia through a one-stop service via JD Health\u2019s platform that combines consultations, prescriptions all the way to the drug delivery and subsequent follow-ups, according to an official statement from Lilly\u2019s official <a href=\"https:\/\/mp.weixin.qq.com\/s\/WLHz0WmsyhvU7-f8Xr_YEg\" title=\"statement\" target=\"_blank\" rel=\"noopener nofollow\" class=\"media-ui-Link_link-tVkXhPLPofs-\" data-component=\"link\">WeChat<\/a> account on Friday. Lilly markets Mounjaro for both obesity and diabetes in China.<\/p>\n","protected":false},"excerpt":{"rendered":"Eli Lilly &amp; Co is partnering with Chinese online healthcare platform JD Health International Inc. to sell its&hellip;\n","protected":false},"author":2,"featured_media":34744,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[275],"tags":[27040,381,718,4595,18,27036,135,475,474,19,17,27037,188,27038,27039,3439,12274],"class_list":{"0":"post-34743","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-healthcare","8":"tag-alibaba-health-information-t","9":"tag-china","10":"tag-drugs","11":"tag-e-commerce","12":"tag-eire","13":"tag-eli-lilly-co","14":"tag-health","15":"tag-health-care","16":"tag-healthcare","17":"tag-ie","18":"tag-ireland","19":"tag-jd-health-international-inc","20":"tag-markets","21":"tag-novo-nordisk-a-s-b","22":"tag-ping-an-healthcare-and-techn","23":"tag-retail","24":"tag-tencent-holdings-ltd"},"share_on_mastodon":{"url":"","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/posts\/34743","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/comments?post=34743"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/posts\/34743\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/media\/34744"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/media?parent=34743"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/categories?post=34743"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/tags?post=34743"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}